Skip to content
Application 021860
- Type
- NDA
- Sponsor
- APIL
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SARAFEM | FLUOXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | Yes | No |
| 002 | SARAFEM | FLUOXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 15MG BASE | Yes | No |
| 003 | SARAFEM | FLUOXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0430-0210 | SARAFEM | fluoxetine hydrochloride | Allergan, Inc. | NDA | Current |
| 0430-0210 | SARAFEM | fluoxetine hydrochloride | Allergan, Inc. | NDA | Current |
| 0430-0215 | SARAFEM | fluoxetine hydrochloride | Allergan, Inc. | NDA | Current |
| 0430-0220 | SARAFEM | fluoxetine hydrochloride | Allergan, Inc. | NDA | Current |